Asparlas 750 U/ML (PF) injection soln, 5ML vials
Ended Awarded Last action
- Contract number
- 36C26221N0653
- Awardee
-
Servier Pharmaceuticals LLC UEI G3YUU3BJQNL4
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $27,644
Award facts
- Contract value 100% obligated
- $27,643.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92161, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $27,644 |
About this award
This federal contract award to Servier Pharmaceuticals LLC is for the supply of ASPARLAS 750 U/ML (PF) INJECTION SOLN, 5ML VIALS to the Department of Veterans Affairs (VA). The $27,643.58 firm-fixed-price contract was awarded on May 21, 2021 and has a completion date of July 6, 2021. The contract is a call against Servier's existing Federal Supply Schedule (FSS) contract with the VA for pharmaceuticals and drugs. No set-aside designation was used. Servier is a for-profit organization that has previously received VA contracts for specialty oncology medications like pegaspargase (Oncaspar) and asparlas to support cancer treatment programs for veterans. This latest award will provide the ASPARLAS injectable solution to the VA's Veterans Integrated Service Network 22 in San Diego, California.
Quick answers
Who was awarded contract 36C26221N0653?
36C26221N0653 was awarded to Servier Pharmaceuticals LLC by Veterans Integrated Service Network 22 (Veterans Health Administration) on May 21, 2021.
How much is contract 36C26221N0653 worth?
The government has obligated $27,644 on 36C26221N0653.
Is contract 36C26221N0653 an order under another contract?
Yes. 36C26221N0653 is a BPA call under 36F79720D0213-36E79721A0003, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26221N0653 competed?
The extent of competition for 36C26221N0653 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award